Brief: Genoway Licenses Its Crispr/Cas9 Technology To UKRI

genOway SA

13/12/2021 17:38

Dec 13 (Reuters) - GENOWAY SA  ALGEN.PA :
    * GENOWAY LICENSES ITS CRISPR/CAS9 TECHNOLOGY TO THE BRITISH
NATIONAL RESEARCH FUNDING AGENCY (UKRI) 
    * ANNOUNCES IT HAS GRANTED CRISPR / CAS9 LICENSE TO
ENGLAND'S
LEADING RESEARCH FUNDER, OPERATING ACROSS THE UK WITH A COMBINED
BUDGET OF OVER £ 9BN FOR SEVEN RESEARCH COUNCILS, INCLUDING ONE
SPECIALIZING IN BIOMEDICAL RESEARCH

Source text for Eikon:  ID:nACT72350 
Further company coverage:  ALGEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00 ;))